What is a comprehensive overview of psychodermatology?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Comprehensive Overview of Psychodermatology

Psychodermatology is a specialized field that addresses the complex interaction between the mind and skin, requiring a multidisciplinary approach involving dermatologists, psychiatrists, psychologists, and primary care physicians for optimal patient outcomes. 1

Classification of Psychodermatological Disorders

Psychodermatological disorders can be categorized into three main groups:

  1. Psychophysiologic (Psychosomatic) Disorders

    • Skin conditions exacerbated by emotional stress but not directly caused by it
    • Examples: urticaria, eczema, psoriasis, acne, seborrheic dermatitis, atopic dermatitis, alopecia areata, rosacea 2
  2. Primary Psychiatric Disorders with Dermatologic Symptoms

    • Psychiatric conditions manifesting with skin changes
    • Examples: trichotillomania, factitial dermatitis, neurotic excoriations, delusions of parasitosis, body dysmorphic disorder 2
  3. Dermatologic Disorders with Secondary Psychiatric Symptoms

    • Disfiguring skin diseases causing psychological suffering
    • Examples: psoriasis, chronic eczema, ichthyosiform syndromes, rhinophyma, neurofibromas, severe acne 2

Assessment and Screening

Clinical Evaluation

  • Perform thorough skin assessment alongside psychiatric evaluation for:
    • Depression (present in up to 60% of psoriasis patients)
    • Anxiety
    • Obsessive-compulsive behaviors
    • Delusional thinking
    • Suicidal ideation (present in approximately 5% of patients with certain skin conditions) 1

Risk Assessment

  • Assess for self-harm, which affects approximately 50% of young people with body dysmorphic disorder (BDD) 3
  • Evaluate suicidal ideation, as BDD is associated with high suicide risk 3
  • Screen for desire for cosmetic procedures, reported by about 50% of young people with BDD 3

Quality of Life Assessment

  • Use dermatology-specific quality of life questionnaires to evaluate disease impact 1
  • Identify stressors that may trigger or exacerbate skin conditions 1
  • Consider cultural and gender factors that may influence patient experience 1

Treatment Approaches

Psychotherapeutic Interventions

  1. Cognitive Behavioral Therapy (CBT)

    • First-line treatment for BDD in young people according to NICE guidelines 3
    • Should incorporate exposure with response prevention (ERP)
    • Should involve family or carers
    • Should be adapted to the developmental level of young people 3
  2. Additional Psychological Techniques

    • Habit reversal training
    • Relaxation techniques (progressive muscle relaxation, mindfulness meditation, guided imagery)
    • Patient education about mind-skin connection 1

Pharmacological Management

  1. For Primary Skin Conditions

    • Standard dermatological treatments for underlying conditions 1
  2. For Pruritus Management

    • First-line: Topical corticosteroids for mild to moderate pruritus
    • Topical doxepin for localized areas
    • Non-sedating H1-antihistamines (cetirizine, loratadine, fexofenadine)
    • Calcineurin inhibitors (tacrolimus, pimecrolimus) for genital involvement 1
  3. Psychotropic Medications

    • Selective Serotonin Reuptake Inhibitors (SSRIs) as second-line treatment for moderate to severe BDD in young people aged 12-18 years who haven't responded adequately to CBT 3
    • Antipsychotics, anxiolytics, and mood stabilizers when indicated 1, 2

Special Considerations

Body Dysmorphic Disorder (BDD)

  • Caution regarding cosmetic procedures: Evidence suggests poor psychological outcomes in people with BDD who undergo cosmetic procedures 3
  • Most patients feel disappointed with results or shift focus to another feature
  • Young people may attempt unsafe "treatments" at home if unable to access professional cosmetic treatments 3

Psychiatric Comorbidities

  • Depression prevalence may be as high as 60% in psoriasis patients 3
  • Approximately 10% of psoriasis patients report wishing to be dead, with 5% reporting active suicidal ideation 3
  • Treatment of psoriasis with biologics like etanercept may decrease depression scores 3

Avoiding Common Pitfalls

  1. Overlooking Psychological Factors

    • Recognize stress as a provoking factor in resistant chronic dermatoses 1
    • Address psychological aspects even when physical symptoms predominate
  2. Treatment Errors

    • Avoid sedating antihistamines due to increased risk of adverse effects, especially in older patients 1
    • Avoid alcohol-containing products that can further dry and irritate the skin 1
    • Avoid crotamiton cream, topical capsaicin, and calamine lotion for generalized pruritus of unknown origin 1
  3. Fragmented Care

    • Implement a multidisciplinary approach involving dermatologists, psychiatrists, psychologists, and primary care physicians 1, 4
    • Ensure dermatologists are trained to initiate basic psychopharmacotherapy and know when to refer to psychiatry 5

Emerging Trends

  • Dedicated psychodermatology clinics are more cost-effective for managing patients with psychodermatological disease 4
  • Growing evidence supports the role of neuroendocrine mediators (adrenocorticotropin, β-endorphin, catecholamines, cortisol) in stress-related skin disorders 6
  • Systemic therapy can improve overall psychosocial wellbeing and positively impact patients' quality of life 1

By understanding and addressing both dermatological and psychological aspects of skin conditions, clinicians can provide more holistic care and achieve better outcomes for patients with psychodermatological disorders.

References

Guideline

Psychodermatology Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[PSYCHODERMATOLOGY].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti, 2016

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Psychodermatology in Clinical Practice: Main Principles.

Acta dermato-venereologica, 2016

Research

Psychodermatology: a comprehensive review.

Indian journal of dermatology, venereology and leprology, 2013

Research

Psychodermatological aspects of atopic dermatitis.

The British journal of dermatology, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.